This Month in Psychopharmacology

Patterns of Cannabis and Alcohol Use for Sleep Initiation in Young Adults

Sleep difficulties are widespread in young adults, with some indivi...

Read More

Starting Benzodiazepines, Antipsychotics in Hospice with Dementia Linked to Increased Mortality

The Medicare hospice benefit was originally designed to care for ca...

Read More

Relapse Criteria in Schizophrenia

Relapse prevention is critical in long-term schizophrenia managemen...

Read More

Novel Benzodiazepines Linked to More Severe Opioid Overdoses

The combination of opioids and benzodiazepines poses a growing chal...

Read More

Brief Cognitive Behavioral Therapy Shows Promise for Suicide Prevention in Military Populations

Suicide attempts among military personnel are notably higher than i...

Read More

Young Investigator Poster Awards

Presented below are the winners of the 2025 NEI Fall Congress Young...

Read More

FDA Approves Lumateperone as Adjunctive Treatment for Major Depressive Disorder

The FDA has approved lumateperone as an adjunctive therapy with an...

Read More

Child and Adolescent Psychiatry Academy

The 2025 NEI Child and Adolescent Psychiatry Academy presented a se...

Read More

GLP-1 Receptor Agonists for the Treatment of Opioid Use Disorders

Opioid Use Disorder (OUD) remains a major public health crisis, wit...

Read More

Lurasidone Efficacious for Depression Across Psychiatric Diagnoses

Depressive symptoms are a key driver of morbidity across multiple p...

Read More

Advancing ADHD Awareness Through Evidence-Based Practice

October is ADHD Awareness Month. The goal of ADHD Awareness Month i...

Read More

Chronic Insomnia Associated with Elevated Risk of Cognitive Decline

Chronic insomnia is prevalent in older adults, affecting up to 70%,...

Read More